Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease

The Journal of Pediatrics
Sudeep KarveElizabeth Andrews

Abstract

We sought to assess the feasibility of using a health insurance claims database to estimate the prevalence and health care utilization and costs among children diagnosed with systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD). This was a retrospective analysis of the LifeLink insurance claims database for the years 2000-2006. Children (0-15 years) and young adults (16-25 years) with ≥ 2 diagnosis claims for SLE or IBD were selected as the 2 cohorts of interest. For each member of the SLE and IBD cohorts, 2 individuals were randomly selected for a matched comparison group. All the analyses were descriptive in nature, CI for differences between means and 2 proportions for measures including health care utilization, comorbidity burden were based on t tests and 2-group tests of proportions. We identified 278 patients with SLE (prevalence estimate: 7.9 per/100000 population) and 1174 patients with IBD (33.2 per/100000 population). The mean annual total medical costs was substantially higher for the SLE (difference: $22223; 95% CI: $14961-$29485) and IBD (difference: $16238; 95% CI: $14395-$18082) cohorts compared with those of the comparator cohort. We observed higher comorbidity burdens in the SLE and IBD cohor...Continue Reading

References

Apr 5, 2000·Journal of Pediatric Gastroenterology and Nutrition·E LindbergH Hildebrand
Oct 17, 2002·Rheumatic Diseases Clinics of North America·Marisa Klein-GitelmanEarl D Silverman
Jan 16, 2004·Gastroenterology·Tjeerd-Pieter van StaaNigel K Arden
Dec 14, 2004·Arthritis and Rheumatism·Michael B NicholMichael H Weisman
Dec 21, 2004·Annals of the Rheumatic Diseases·C-S YeeC Gordon
Sep 1, 2007·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·María J MolinaLuis M Vilá
Oct 16, 2008·Gastroenterology·Michael D KappelmanJonathan A Finkelstein
Jan 13, 2009·Journal of Occupational and Environmental Medicine·Ginger CarlsRon Z Goetzel
Oct 6, 2010·Health Affairs·Rachael L FleurenceJeroen P Jansen
Dec 9, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nicholas F Marko, Robert J Weil

❮ Previous
Next ❯

Citations

Dec 3, 2014·Pediatrics International : Official Journal of the Japan Pediatric Society·Masato TakeuchiKiyohide Fushimi
Apr 18, 2016·Current Gastroenterology Reports·Itishree TrivediLaurie Keefer
Jun 13, 2015·Gastroenterology Research and Practice·Itishree Trivedi, Laurie Keefer
Aug 15, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jessie P BuckleyMichael D Kappelman
Jun 21, 2016·Expert Review of Clinical Immunology·Kaija-Leena Kolho, Antti Ainamo
Dec 27, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·David A JohnsonDouglas J Robertson
Sep 30, 2017·Inflammatory Bowel Diseases·Stacy A KahnMartha Skup
May 28, 2020·Journal of Pediatric Gastroenterology and Nutrition·Ewa StawowczykMałgorzata Mossakowska
Jun 19, 2019·Inflammatory Bowel Diseases·Wael El-MataryEric I Benchimol
Jul 12, 2019·Journal of the Canadian Association of Gastroenterology·M Ellen KuenzigSanjay K Murthy
Aug 28, 2020·Frontiers in Pediatrics·Sumedh BeleMaria J Santana
Jun 12, 2021·Alimentary Pharmacology & Therapeutics·Reinier Cornelis Anthonius van LinschotenRachel Louise West

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.